Cristiana Maximiano, Marta Ribeiro Silva, Fábia Carvalho, Juliana Almeida, Maria Miguel Gomes, Sofia Martins, Olinda Marques, Alexandra Estrada, Almerinda Pereira, Ana Antunes
INTRODUCTION: The prevalence of neonatal hyperthyroidism (HN) due to maternal Graves Disease (GD) ranges from 0.1 to 2.7%. It may occur in pregnant women with the following: active DG, after treatment with radioactive iodine, anti-thyroid or thyroidectomy or with a previous child with hyperthyroidism. The aim of our observational study was to evaluate the follow-up of infants born to mothers with GD at a Tertiary Hospital prior to the implementation of a follow-up protocol. METHODS: This was a retrospective observational study using data from the medical records of mothers with a diagnosis of GD and their newborns from January 2013 until May 2018...
December 29, 2020: Endocrinología, Diabetes y Nutrición